Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Int J Gynecol Pathol. 2022 Mar 1;41(2):126–131. doi: 10.1097/PGP.0000000000000775

Table 1.

Antibodies used in this study

Antibody Clone Dilution Source
AE1/AE3 AE1/AE3 1:100 Dako (Denmark)
ß-catenin 14 Predilute Cell Marque (CA, USA)
CDX2 EPR2764Y Predilute Cell Marque (CA, USA)
Chromogranin LKZH10 Predilute Ventana (AZ, USA)
CK7 SP52 Predilute Ventana (AZ, USA)
CK20 SP33 Predilute Ventana (AZ, USA)
ER SP1 Predilute Ventana (AZ, USA)
INSM1 A-8 1:200 Invitrogen (CA, USA)
MSH6 44 Predilute Cell Marque (CA, USA)
PAX8 MRQ-50 Predilute Cell Marque (CA, USA)
PMS2 EPR3947 Predilute Cell Marque (CA, USA)
P16 E6H4 Predilute Ventana (AZ, USA)
p53 DO-7 Predilute Ventana (AZ, USA)
P63 BC4A4 Predilute Biocare (CA, USA)
Synaptophysin SP11 Predilute Ventana (AZ, USA)